Trephination for primary pediatric pilonidal sinus disease: medium term functional and recurrence outcome of a large cohort
Topic overview
This retrospective study of 100 pediatric patients evaluates medium-term outcomes of trephination for primary pilonidal sinus disease over 31 months median follow-up. While functional recovery was excellent with minimal sick days, recurrence rates were notable with 18% requiring reoperation, mostly within two years.
Key takeaways
- Trephination offers excellent functional recovery: median 7 sick days and return to full activity in 14 days with minimal analgesic use.
- Recurrence rates are significant: 37% experience recurrent pain, 35% discharge, and 18% require reoperation within medium-term follow-up.
- Most adverse outcomes occur early: 80-85% of recurrences and 95% of reoperations happen within the first 2 postoperative years.
- No demographic or clinical factors predicted recurrence, suggesting current patient selection criteria may need refinement.
- Medium-term efficacy is limited despite good functional outcomes, warranting careful patient counseling about recurrence risk.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Trephination for primary pediatric pilonidal sinus disease: medium term functional and recurrence outcome of a large cohort. GlobalCastMD Medical Library. 2024-12-21. https://dev.library.globalcastmd.com/article/9558?via_space=staycurrentmd
Comments